Google
AMRN — AMARIN CORPORATION PLC (Healthcare >> Drug Manufacturers - General)
AMRN FAQ
What is AMRN's ROE?
AMARIN CORPORATION PLC reports a Return on Equity (ROE) of -7.48%.
What is AMRN's dividend yield?
AMARIN CORPORATION PLC offers a dividend yield of 0.00%.
What is AMRN's Deepscope Quality Score?
Deepscope rates AMRN's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy AMRN?
Deepscope's AI Timing Score for AMRN is 64 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does AMRN belong to?
AMARIN CORPORATION PLC is classified under the Healthcare >> Drug Manufacturers - General sector on the NASDAQ exchange.
|
USD 14.90
Price
0.14
(0.95%)
Day Change
|
|
|---|
AMRN, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 87 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 14.90 |
| PBV / Sector |
0.69 / 2.98
GREAT
|
| Earning Per Share | -1.60 |
| PE / Sector |
N/A / 24.52
|
| PEG or PE/Growth / Sector |
N/A / 0.08
|
| Average 1M Daily Value |
1.06 M
GREAT
|
| Average 1W Daily Value |
1.61 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
52% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-12 09:43:11 |
| Symbol | AMRN |
| Name | AMARIN CORPORATION PLC |
| Sector | Healthcare >> Drug Manufacturers - General |
| Market | NASDAQ |
| Listed Shares | 20.97 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 312.23 / 243,975.41 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: One Central Plaza, Dublin, Ireland, D02 K7K5
Phone: 353 0 166 99020
Website: https://www.amarincorp.com
Employees: 80
Description: Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
ME vs SECTOR Healthcare >> Drug Manufacturers - General
Click a bubble to view stock details · Bubble size represents market capitalization share
